Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|June 7, 2016

Thermo Fisher Scientific Releases New Biopharmaceutical Characterization Technology

The company showcased new technologies at ASMS for biopharmaceutical characterization.

Thermo Fisher Scientific released new technologies for biopharmaceutical characterization at the American Society for Mass Spectrometry Conference (ASMS) in Texas, the company said in a press announcement. One of the featured products included Thermo Scientific’s Q Exactive BioPharma MS/MS Hybrid Quadropole-Orbitrap mass spectrometer. The spectrometer uses high-resolution, accurate-mass (HRAM) capabilities of the Orbitrap mass analyzer to enable key workflows for protein characterization in a single instrument. Combined with recommended sample preparation and analysis methods using Thermo Scientific reagents, columns, ultra high-pressure liquid chromatography (UHPLC) and data processing technologies, the Q Exactive BioPharma system provides a comprehensive solution for biopharmaceutical characterization. The company also showcased its new workflow driven software and cloud solutions to allow users to analyze insights in several applications, including proteomics, metabolomics, food safety, and biopharmaceutical characterization.

Source: Thermo Fisher Scientific


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.